LMSa is a reliable parameter for predicting long-term clinical deterioration or death in patients with hypertrophic cardiomyopathy.
Does LMSa from tissue Doppler imaging predict clinical deterioration or death in patients with hypertrophic cardiomyopathy?
LMSa derived from tissue Doppler imaging may help identify patients with hypertrophic cardiomyopathy who are at risk for clinical deterioration or death.
Absolute Event Rate: 0% vs 0%
In conclusion, LMSa seems to be a reliable parameter that can be used in predicting the HC patients at risk for clinical deterioration or death at long-term follow-up.
Bayrak et al. (Sat,) reported a other. LMSa is a reliable parameter for predicting long-term clinical deterioration or death in patients with hypertrophic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: